BioCentury
ARTICLE | Company News

Chelsea, Synergia deal

May 15, 2006 7:00 AM UTC

CHTP signed a letter of intent to acquire Synergia's IP covering a controlled-release formulation of droxidopa to treat neurogenic orthostatic hypotension. Droxidopa, a synthetic amino acid, is market...